Filing Details

Accession Number:
0001225208-14-013102
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-05-15 18:17:23
Reporting Period:
2014-05-12
Filing Date:
2014-05-15
Accepted Time:
2014-05-15 18:17:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
810509 Navidea Biopharmaceuticals Inc. NAVB In Vitro & In Vivo Diagnostic Substances (2835) 311080091
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1559381 J. William Regan 5600 Blazer Parkway
Suite 200
Dublin OH 43017
Svp-Global Reg Affairs&Quality No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-05-12 4,400 $1.43 9,400 No 4 P Direct
Common Stock Acquisiton 2014-05-12 500 $1.43 9,900 No 4 P Direct
Common Stock Acquisiton 2014-05-12 100 $1.43 10,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct